期刊文献+

不同羟乙基淀粉对心肺转流血液循环和凝血功能的影响 被引量:2

Effcet of hydroxyethyl starch with different molecular weight and degrees of substitution on circulation and coagulation during cardiopulmonary bypass
下载PDF
导出
摘要 目的比较不同分子量和取代级羟乙基淀粉(6%羟乙基淀粉200/0.5和6%羟乙基淀粉130/0.4)对心肺转流患者血流动力学、血液流变学和凝血功能的影响。方法选择60例行房间隔缺损修补术和(或)室间隔缺损修补术患者,随机分为两组(n=30):6%羟乙基淀粉200/0.5组(A组)和6%羟乙基淀粉130/0.4组(B组)。A组预充6%羟乙基淀粉200/0.5800ml和复方乳酸钠400ml,B组预充6%羟乙基淀粉130/0.4800ml和复方乳酸钠400ml。分别于诱导前(基础状态)、CPB15min、鱼精蛋白中和肝素后10min、术毕时监测患者血流动力学参数(HR、MAP、CVP)和血液流变学参数(全血高、低切粘度,血浆粘度),并同时抽血检测凝血功能(PT、APTT、FIB、ACT、Plt)。结果与基础值比较,两组在转流后全血高、低切粘度和血浆黏度明显下降(P<0.05),PT、APTT均有所延长(P<0.05),FIB、Plt均有所减少(P<0.05),HR、MAP、CVP、ACT差异无统计学意义(P>0.05)。两组组间各时点血流动力学、血液流变学和凝血功能指标差异均无统计学意义(P>0.05)。结论 6%羟乙基淀粉200/0.5或6%羟乙基淀粉130/0.4作为CPB预充液,均可维持血流动力学稳定,改善微循环,但对凝血功能有可耐受的影响。 Objective To compare the effects of 6% hydroxyethyl starch 200/0.5 (6% HES200/0.5) and 6% hy- droxyethyl starch 13 0/0.4 (6% HES 130/0.4) on haemodynamics, hemorheology and coagulation fimction during cardiopulmonary bypass. Methods Sixty adult patients undergoing repair of atrial septal defect and (or) ventricular septal defect were randomly divided into two groups, each with 30 cases: 6% HES200/0.5 group (group A) and 6% HES:300/0.4 group (group B). In group A, the priming fluid was 800 ml 6% HES200/0.5 and 400 ml lactated Ringer's solution. In group B, the priming fluid was 800 ml 6% HES:30/0.4 and 400 ml lactated Ringer' s solution. Haemodynamics parameters (HR, .MAP and CVP), hemorheology parameters (whole blood viscosity and plasma viscosity) and coagulation parameters (PT, APTT, FIB, ACT and Plt) were evaluated before induction of anesthesia (baseline), at 15 rain of CPB, at 10 rain after protamine injection, and at the end of operation. Results Whole blood viscosity, plasma viscosity, FIB and Plt were significantly lower (P〈0.05), while PT and APTT were significantly higher after CPB (P〈0.05), compared with that before induction of anesthesia. There were no significant differences in HR, MAP, CVP and ACT after CPB (P〉 0.05). No significant differences were found between the two groups in terms of hacmodynamics, hemorheology and coagulation function. Conclusion 6% HES200/0.5 or 6% HES130/0.4 can maintain hacmodynamics stabile and improve mi- crocirculation during cardiopulmonary bypass, but both of them can impact coagulation function, although the parame- ters are still in normal range.
出处 《海南医学》 CAS 2011年第24期21-24,共4页 Hainan Medical Journal
关键词 羟乙基淀粉 心肺转流 血流动力学 血液流变学 凝血功能 Hydroxyethyl starc Cardiopulmonary bypass Haemodynamics Hemorheology Coagulation
  • 相关文献

参考文献14

  • 1Gandhi SD, Weiskopf RB, Jungheinrich C, et al. Volume replace- ment therapy during major orthopedic surgery using Voluven (hy- droxyethyl starch 130/0.4) or hctastarch [J]. Anesthesiology, 2007, 106(6): 1120-1127.
  • 2Felfemig M, Franz A, Braunlich P, et al. The effects of hydroxyeth- yl starch solutions on thromboelastography in preoperative male pa- tients [J]. Acta Anaesthesiol Scand, 2003, 47(1): 70-73.
  • 3Asopa S, Elahi M. Hemodilution during cardiopuhnonary bypass: optimal hematocrit for safe outcome [J]. Acute Card Care, 2007, 9 (1): 63-64.
  • 4Morariu AM, Gu YI, Huet RC, et al. Red blood cell aggregation dur- ing cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation? [J]. Eur J Cardiothorac Surg, 2004, 26(5): 939-946.
  • 5Jungheinrich C, Sauermann W, Beperling F, et al. Volume efficacy and reduced influence on measures of coagulation using hydroxy- ethyl starch 130/0.4(6% ) with an optimized in vivo molecular weight in orthopaedic surgery: a randomized, double-blind study [J]. Drugs RD, 2004, 5(1): 1-9.
  • 6Boks P.H, Wijcrs MJ, Hofland J, et al. Low moleoular starch versus gelatin plasma expander during CPB; dose it make a difference? [J]. Perfusion, 2007, 22(5): 333-337.
  • 7张秀华,黄宇光.围术期羟乙基淀粉容量治疗的安全性[J].临床麻醉学杂志,2006,22(12):937-938. 被引量:17
  • 8Undar A. Effect of hypothcrrnic cardiopulmonary bypass on blood viscoelasticity in pediatric cardiac patients [J]. ASAIO, 2005, 51(5): 522-524.
  • 9Rinder C. Cellular inflammatory response and clinical outcome in cardiac surgery [J]. Curr Opin in Anaesthesiol, 2006, 19(1): 65-68.
  • 10Ochoa JJ, Vilehez MJ, Palacios MA, et al. Melatonin protects against lipid peroxidation and membrane rigidity in erythroeytes from patients undergoing eardiopulmonary bypass surgery [J]. J Pi- neal Res, 2003, 35(2): 104-108.

二级参考文献18

  • 1Trouwborst A,van Woerlem ECSM,van Daele M,et al.Acute hypervolemic hemodilution to avoid blood transfusion during major surgery[J].Lancet,1990,336:1295-1297.
  • 2Kumar R,Chakraborty I,Sehgal R.A prospective randomized study comparing two techniques of pefiopcrative blood conservation:iso-volemic hemodilution and hypervolcmic hemodilution[J].Anesth Analg,2002,95(5):1154-1161.
  • 3Franc A,Braunlich P,Gamsjager T,et al.The effects of hydroxy-ethy starches of varying molecular weights on platelet function[J].Anesth Analg,2001,92:1402-1407.
  • 4Frese A,Rinke D,Kfinnecke M,et al.Platelet aggregation during abdominal surgery in an experimental pigmodel:the effects of presurgical antibiotic protocols and volume replacement with hydroxy-ethylstarch[J].Thromb Res,2000,97(3):143-151.
  • 5Rehrn M,Hailer H,orth V,et al.Changes in blood volume and hematocrit during acute preoperative volume loading with 5%albumin or 6%hetastarch solution in patients before radical hysteretomy[J].Anesthesiology,2001,95(4):849-856.
  • 6Kourad CJ,Markl TJ,Schuepfer GK,et al.In vitro effects of different medium molecular hydroxyethyl starch solution and lactated ringers solution on coagulation using Sonoclot[J].Anesth Analg,2000,90(2):274-279.
  • 7Huct G,Siemons AW,van Rooyen-Butijn WT,et al.A novel by-droxyethyl starch(Voluven)for effective perioperative plasma volume substitutionin cardiac surgery[J].Can J Anesth,2000,47(12):1207-1215.
  • 8Langeron O,Doelberg M,Aug ET,et al.Voluven,alower substituted novel hydroxyethyl starch (HES 130/0.4),causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5[J].Anesth Analg,2001,92:855-862.
  • 9Caveh M,Caroline T,Thierry B,et al.Novel starches:single-dose pharmacokinetics and effects on blood coagulation[J].Anesthesiol-ogy,2007,106:132-143.
  • 10Boldt J.New light on intravascular volume replacement regimens:what did we learn from the past three years? Anesth Analg,2003,97:1595-1604.

共引文献18

同被引文献21

  • 1钟思干,李桂平,李沅洲,李绪娴.左旋卡尼汀对冠心病并糖尿病患者心绞痛及糖脂代谢的影响[J].广东医学,2005,26(4):553-554. 被引量:2
  • 2Badruzzaman M, Hossaim A, Adhikary AB, et al. Evaluation ofmyocardial protection in off-pump vs. on-pump coronary bypasssurgery by troponin I estimation [J]. Bangladesh Med Res CouncBull, 2010,36(3): 93-96.
  • 3Wei-hua L, Jun-yu H, Chang-qing S, et al. Study on the relationshipof Cpla2, CK-MB, and membrane phospholipid content in acutemyocardial infarction [J]. Heart Vessels, 2011,26(1): 64-68.
  • 4Langeron O. Voluven, a lower substituted novel hydroxyethyl starch(HES 130/0.4), causes fewer effects on coagulation in major ortho-pedic surgery than HES 200/0.5 [J]. Anesth Analg, 2001,92(2):855-862.
  • 5Okumura S, Vatner DE, Kurotani R, et al. Disruption of type 5 ade-nylyl cyclase enhances desensitization of cyclic adenosine mono-phosphate signal and increases Akt signal with chronic catechol-amine stress [J]. Circulation, 2007, 116(16): 1776-1783.
  • 6Lewin G, Matus M, Basu A, et al. Critical role of transcription factorcyclic AMP response element modulator in beta 1 -adrenoceptor-medi-ated cardiac dysfunction [J]. Circulation, 2009,119(1): 79-88.
  • 7KHOYNEZHAD A. Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon[ J]. Ann Thorac Surg, 2004, 78(3) : 1109 -1118.
  • 8TARANTINE G. Metabolic treatment with L - camitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial [ J ]. Cardiology, 2006, 106 (4) : 215 - 223.
  • 9CATALYUREK H, OKTAY G, GUZELOGLU M, et al. Insulin - blood cardioplegia decreases matrix metalloproteinase activity in is- chaemia- reperfusion injury during coronary artery bypass surgery [J]. JInt MedRes, 2008, 36(3): 551 -558.
  • 10LANGERON O. Voluven, a lower substituted novel hydroxyethyl starch ( HES 130/0. 4 ), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5 [ J ]. Anesth Analg, 2001,92(4) : 855 -862.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部